• Citer

Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia.

par Gérard, C.;Bruyns, C;Marchant, Arnaud ;Abramowicz, Daniel ;Vandenabeele, P;Delvaux, Anne ;Fiers, Walter;Goldman, Michel ;Velu, Thierry
Référence The Journal of experimental medicine, 177, 2, page (547-550)
Publication Publié, 1993-02

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Résumé :

Because of its ability to efficiently inhibit in vitro cytokine production by activated macrophages, we hypothesized that interleukin (IL) 10 might be of particular interest in preventing endotoxin-induced toxicity. We therefore examined the effects of IL-10 administration before lipopolysaccharide (LPS) challenge in mice. A marked reduction in the amounts of LPS-induced tumor necrosis factor (TNF) release in the circulation was observed after IL-10 pretreatment at doses at low as 10 U. IL-10 also efficiently prevented the hypothermia generated by the injection of 100 micrograms LPS. Finally, pretreatment with a single injection of 1,000 U IL-10 completely prevented the mortality consecutive to the challenge with 500 micrograms LPS, a dose that was lethal in 50% of the control mice. We conclude that IL-10 inhibits in vivo TNF secretion and protects against the lethality of endotoxin in a murine model of septic shock.